Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 182
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #227: A Closer Look at Compass’ 6-Month Data; AtaiBeckley Deal Update; ‘Rysanso’ Brand MDMA?
Compass Closes Out Phase 3 With 6-Month COMP006 Data, Eyes H1’27 Launch
Psychedelic Policy Briefing: Week of July 6, 2026
Psychedelics Today at the Aspen Psychedelic Symposium
The Framework Gap in Psychedelic Practice: An Introduction to the 8-Circuit Model of Consciousness
Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental...
Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year...
GH Research Reports First Quarter 2022 Financial Results and Provides Business...
COMPASS Pathways presents largest ever study of psilocybin therapy, at American...
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine...
Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians...
Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet...
Numinus Applies for International Patent Filing of Psychedelics Production Process
Small Pharma Reports Highlights for the Fiscal Year Ended February 28,...
Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and...
Load more